Do you want to read an article? Please log in or register.
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial
Atrial Fibrillation
Related content
Heart, Artery and Coronary DiseasesTherapy and Intervention
Mortality After Repeat Revascularization Following PCI or Coronary Artery Bypass Grafting for Left Main Disease: The EXCEL Trial
JACC Cardiovasc Interv.
Giustino G, Serruys PW, Sabik JF 3rd, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Ragosta M 3rd, Kron IL, Liu Y, Zhang Z, McAndrew T, Dressler O, Généreux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW
doi: 10.1016/j.jcin.2019.09.019.
Heart, Artery and Coronary Diseases
B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial
Circulation.
Redfors B, Chen S, Crowley A, Ben-Yehuda O, Gersh BJ, Lembo NJ, Brown WM 3rd, Banning AP, Taggart DP, Serruys PW, Kappetein AP, Sabik JF 3rd, Stone GW
doi: 10.1161/CIRCULATIONAHA.
Therapy and Intervention
Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial
JACC Cardiovasc Interv.
Diamond J, Madhavan MV, Sabik JF , Serruys PW, Kappetein AP, Leon MB, Taggart DP, Berland J, Morice MC, Gersh BJ, Kandzari DE, Dressler O, Stone GW
doi: 10.1016/j.jcin.2018.
Heart, Artery and Coronary Diseases
Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial
JACC Cardiovasc Interv.
Serruys PW, Cavalcante R, Collet C, Kappetein AP, Sabik JF 3rd, Banning AP, Taggart DP, Sabaté M, Pomar J, Boonstra PW, Lembo NJ, Onuma Y, Simonton CA, Morice MC, McAndrew T, Dressler O, Stone GW
doi: 10.1016/j.jcin.2018.03.051.
Heart Failure
Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial
Eur J Heart Fail.
Thuijs DJFM, Milojevic M, Stone GW, Puskas JD, Serruys PW, Sabik JF 3rd, Dressler O, Crowley A, Head SJ, Kappetein AP
doi: 10.1002/ejhf.1681.
COMMENTED
Therapy and Intervention
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
★ 3
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
N Engl J Med.
Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM 3rd, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Pagé P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Généreux P, Crowley A, Dressler O, Serruys PW, EXCEL Trial Investigators.
doi: 10.1056/NEJMoa1909406.
COMMENTED
Heart, Artery and Coronary Diseases
Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction
★ 0
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
J Am Coll Cardiol
Park S, Ahn JM, Kim TO, Park H, Kang DY, Lee PH, Jeong YJ, Hyun J, Lee J, Kim JH, Yang Y, Choe K, Park SJ, Park DW, IRIS-MAIN Registry Investigators.
doi: 10.1016/j.jacc.2020.07.047
Heart, Artery and Coronary DiseasesTherapy and Intervention
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials
Eur Heart J.
Ahmad Y, Howard JP, Arnold AD, Cook CM, Prasad M, Ali ZA, Parikh MA, Kosmidou I, Francis DP, Moses JW, Leon MB, Kirtane AJ, Stone GW, Karmpaliotis D
doi: 10.1093/eurheartj/ehaa135.
Therapy and Intervention
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial
Lancet.
Thuijs DJFM, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Holmes DR Jr, Curzen N, Davierwala P, Noack T, Milojevic M, Dawkins KD, da Costa BR, Jüni P, Head SJ, SYNTAX Extended Survival Investigators.
doi: 10.1016/S0140-6736(19)31997-X.